Martin Brandl

6.6k total citations
155 papers, 5.3k citations indexed

About

Martin Brandl is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, Martin Brandl has authored 155 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pharmaceutical Science, 59 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Martin Brandl's work include Drug Solubulity and Delivery Systems (56 papers), Lipid Membrane Structure and Behavior (41 papers) and Advanced Drug Delivery Systems (30 papers). Martin Brandl is often cited by papers focused on Drug Solubulity and Delivery Systems (56 papers), Lipid Membrane Structure and Behavior (41 papers) and Advanced Drug Delivery Systems (30 papers). Martin Brandl collaborates with scholars based in Denmark, Germany and Norway. Martin Brandl's co-authors include Annette Bauer‐Brandl, Gert Fricker, Gøril Eide Flaten, Rolf Schubert, Stefan Hupfeld, Kerstin J. Frank, Stephen T. Buckley, Kristina Luthman, Sarah Fischer and Andreas Sachse and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Martin Brandl

152 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Brandl Denmark 41 2.6k 1.9k 1.1k 865 660 155 5.3k
Hadi Valizadeh Iran 45 2.4k 0.9× 2.2k 1.1× 1.7k 1.6× 824 1.0× 604 0.9× 244 7.0k
Alfred Fahr Germany 44 2.6k 1.0× 2.7k 1.4× 909 0.9× 622 0.7× 567 0.9× 180 7.1k
Kazutaka Higaki Japan 37 2.0k 0.8× 1.3k 0.7× 1.1k 1.0× 653 0.8× 756 1.1× 167 5.0k
Raimar Löbenberg Canada 39 3.5k 1.4× 1.3k 0.7× 1.0k 1.0× 1.2k 1.4× 573 0.9× 197 6.8k
Natalie L. Trevaskis Australia 30 2.9k 1.1× 1.5k 0.8× 609 0.6× 915 1.1× 1.1k 1.7× 84 5.8k
Bradley D. Anderson United States 41 1.7k 0.6× 2.2k 1.1× 615 0.6× 887 1.0× 601 0.9× 144 5.2k
Ramesh Panchagnula India 42 2.6k 1.0× 1.0k 0.5× 911 0.9× 418 0.5× 737 1.1× 125 5.2k
Chong‐Kook Kim South Korea 40 3.0k 1.2× 1.6k 0.8× 916 0.9× 405 0.5× 342 0.5× 175 5.6k
Sung‐Joo Hwang South Korea 43 3.3k 1.3× 1.0k 0.5× 1.1k 1.0× 1.3k 1.5× 313 0.5× 198 6.5k
Zhonggui He China 32 1.4k 0.5× 1.1k 0.5× 1.0k 1.0× 513 0.6× 420 0.6× 133 3.5k

Countries citing papers authored by Martin Brandl

Since Specialization
Citations

This map shows the geographic impact of Martin Brandl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Brandl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Brandl more than expected).

Fields of papers citing papers by Martin Brandl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Brandl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Brandl. The network helps show where Martin Brandl may publish in the future.

Co-authorship network of co-authors of Martin Brandl

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Brandl. A scholar is included among the top collaborators of Martin Brandl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Brandl. Martin Brandl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandl, Martin, et al.. (2026). Microdialysis during in vitro lipolysis explains enhanced permeation of indomethacin from phospholipid-based amorphous solid dispersions. European Journal of Pharmaceutical Sciences. 220. 107480–107480.
2.
Bauer‐Brandl, Annette, et al.. (2025). Untangling “dissolved” drug species from various formulations of a poorly soluble drug: Sampling methods, mechanistic insights, and IVIVC. Journal of Pharmaceutical Sciences. 114(8). 103884–103884. 3 indexed citations
3.
Bauer‐Brandl, Annette, et al.. (2025). Looking behind the Solubilization Curtain: Microdialysis Provides Near-Real-Time Noncolloidal Drug Concentrations during In Vitro Lipolysis. Molecular Pharmaceutics. 22(11). 6670–6680. 1 indexed citations
4.
Bauer‐Brandl, Annette, et al.. (2025). Indomethacin forms elusive nanoparticles with calcium in situ causing enhanced permeation across a biomimetic barrier. International Journal of Pharmaceutics. 684. 126149–126149. 2 indexed citations
5.
Stillhart, Cordula, et al.. (2024). A high-throughput micro-scale workflow to quantify molecularly dissolved drug concentrations under solubilizing conditions. Journal of Pharmaceutical Sciences. 114(2). 1485–1494. 1 indexed citations
6.
Parrott, Neil, et al.. (2024). Oral Absorption from Surfactant-Based Drug Formulations: The Impact of Molecularly Dissolved Drug on Bioavailability. Journal of Pharmaceutical Sciences. 113(10). 3054–3064. 11 indexed citations
7.
Stillhart, Cordula, et al.. (2023). Combining in vitro dissolution/permeation with microdialysis sampling: Capabilities and limitations for biopharmaceutical assessments of supersaturating drug formulations. European Journal of Pharmaceutical Sciences. 188. 106533–106533. 10 indexed citations
8.
Grohganz, Holger, et al.. (2023). Interaction of liposomes with bile salts investigated by asymmetric flow field-flow fractionation (AF4): A novel approach for stability assessment of oral drug carriers. European Journal of Pharmaceutical Sciences. 182. 106384–106384. 10 indexed citations
9.
Bauer‐Brandl, Annette, et al.. (2022). In-vitro dynamic dissolution/bioconversion/permeation of fosamprenavir using a novel tool with an artificial biomimetic permeation barrier and microdialysis-sampling. European Journal of Pharmaceutical Sciences. 181. 106366–106366. 10 indexed citations
10.
Holsæter, Ann Mari, et al.. (2022). How docetaxel entrapment, vesicle size, zeta potential and stability change with liposome composition–A formulation screening study. European Journal of Pharmaceutical Sciences. 177. 106267–106267. 35 indexed citations
11.
Jacobsen, Ann-Christin, et al.. (2021). ‘Stirred not Shaken!’ Comparing Agitation Methods for Permeability Studies Using a Novel Type of 96-Well Sandwich-Plates. Journal of Pharmaceutical Sciences. 111(1). 32–40. 8 indexed citations
12.
Jacobsen, Ann-Christin, Sune F. Nielsen, Martin Brandl, & Annette Bauer‐Brandl. (2020). Drug Permeability Profiling Using the Novel Permeapad® 96-Well Plate. Pharmaceutical Research. 37(6). 93–93. 38 indexed citations
13.
Stein, Paul C., Annette Bauer‐Brandl, Danny Riethorst, et al.. (2019). Co-existing colloidal phases of human duodenal aspirates: Intraindividual fluctuations and interindividual variability in relation to molecular composition. Journal of Pharmaceutical and Biomedical Analysis. 170. 22–29. 15 indexed citations
14.
Jacobsen, Ann-Christin, Anna Krupa, Martin Brandl, & Annette Bauer‐Brandl. (2019). High-Throughput Dissolution/Permeation Screening—A 96-Well Two-Compartment Microplate Approach. Pharmaceutics. 11(5). 227–227. 20 indexed citations
15.
Rosenberg, Jörg, et al.. (2018). PermeaLoop™, a novel in vitro tool for small-scale drug-dissolution/permeation studies. Journal of Pharmaceutical and Biomedical Analysis. 156. 247–251. 27 indexed citations
16.
Rosenberg, Jörg, et al.. (2017). Evaluation of a dynamic dissolution/permeation model: Mutual influence of dissolution and barrier-flux under non-steady state conditions. International Journal of Pharmaceutics. 522(1-2). 50–57. 25 indexed citations
17.
Frank, Kerstin J., Ulrich Westedt, Karin M. Rosenblatt, et al.. (2014). What Is the Mechanism Behind Increased Permeation Rate of a Poorly Soluble Drug from Aqueous Dispersions of an Amorphous Solid Dispersion?. Journal of Pharmaceutical Sciences. 103(6). 1779–1786. 96 indexed citations
18.
Frank, Kerstin J., Karin M. Rosenblatt, Ulrich Westedt, et al.. (2012). Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: True supersaturation vs. apparent solubility enhancement. International Journal of Pharmaceutics. 437(1-2). 288–293. 128 indexed citations
19.
Schulze, Sandra, et al.. (2009). Vesicular phospholipid gel-based depot formulations for pharmaceutical proteins: Development and in vitro evaluation. Journal of Controlled Release. 142(3). 319–325. 47 indexed citations
20.
Iro, H., et al.. (1987). [Significance of percutaneous endoscopically controlled gastrostomy in the prevention and therapy of esophagotracheal fistula following long-term intubation].. PubMed. 22(6). 283–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hadi Valizadeh Breakdown of academic impact, for papers by Alfred Fahr Breakdown of academic impact, for papers by Kazutaka Higaki Breakdown of academic impact, for papers by Raimar Löbenberg Breakdown of academic impact, for papers by Natalie L. Trevaskis Breakdown of academic impact, for papers by Bradley D. Anderson Breakdown of academic impact, for papers by Ramesh Panchagnula Breakdown of academic impact, for papers by Chong‐Kook Kim Breakdown of academic impact, for papers by Sung‐Joo Hwang Breakdown of academic impact, for papers by Zhonggui He
Rankless by CCL
2026